Study of Gefitinib and Docetaxel as Salvage Therapy in Advanced Pancreatic Carcinoma
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This is a phase II, open-label trial of Gefitinib and docetaxel in patients having one prior
regimen of chemotherapy for with metastatic pancreatic carcinoma.